Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the estimation of nicorandil in human plasma

Biomedical Chromatography

Volumn 20, Issue 9, 2006, Pages 864-869

  Bhatt, Jignesh ^a,b   Jangid, Arvind ^a   Shah, Bhavin ^a   Shetty, Raghavendra ^a   Kambli, Sandeep ^a   Subbaiah, Gunta ^a   Singh, Sadhana ^b  

^a Torrent Research Centre   (India)

^b M L SUKHADIA UNIVERSITY   (India)

Author keywords

Human plasma; LC MS MS; Nicorandil

Indexed keywords

EXTRACTION; LIQUID CHROMATOGRAPHY; PHASE SEPARATION; PLASMA (HUMAN);

ANALYTES; CHROMATOGRAPHIC SEPARATIONS; HUMAN PLASMAS; INTERNAL STANDARDS; LC-MS-MS; LC.MS/MS; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; NICORANDIL; SENSITIVE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; SOLID PHASE EXTRACTION TECHNIQUES;

MASS SPECTROMETRY;

IMIPRAMINE; NICORANDIL;

ACCURACY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; LIQUID CHROMATOGRAPHY; PLASMA; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 33748924167     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.608     Document Type: Article

References (12)

1. Andrensek S and Smidovnik A. Routine and sensitive method for determination of nicorandil in human plasma developed for liquid chromatography with ultra violet and mass spectrometric detection. Journal of Chromatography 1999; 735: 103.
2. Bachart EL and Fung H-L. High-performance liquid chromatographic method for stability and pharmacokinetic studies of nicorandil. Journal of Chromatography 1993; 619: 336.
3. Frydman AM, Chapelle P, Deikmann H and Bruno R. Pharmacokinetics of nicorandil. The American Journal of Cardiology 1989; 663: 25.
4. Gomita Y, Furuno K and Eto K. Rapid and simple determination of nicorandil in rat plasma using a solid-phase extraction column. Journal of Chromatography 1990; 528: 509.
5. Kinoshita M and Sakai K. Pharmacology and therapeutic effects of nicorandil. Cardiovascular Drugs and Therapy 1990; 4: 1075.
6. Kinoshita M, Nishikawa S, Sawamura M, Yamaguchi S, Jitsunami K, Itoh M, Motomura M, Bito K, Mashiro I and Kawakita S. Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris. The American Journal of Cardiology 1986; 58: 733.
7. Mawatari K, Nakamura Y and Shimizu R. Fluorimetric determination of nicorandil in human plasma by a high-performance liquid chromatographic-post column ultraviolet radiation system equipped with on-line back-pressure tubing. Journal of chromatography B 1996; 679: 155.
8. Ojha A and Paragal A. Determination of nicorandil concentration in human plasma using liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 1999; 21: 175.
9. Sakai K, Shirai Y and Nabata H. Cardiovascular effects of a new coronary vasodilator N-(2-hyrdoxyethyl) nicotinamide nitrate (SG-75): composition with nitroglycerin and diltiazem. Journal of Cardiovascular Pharmacology 1981; 3: 139.
10. Schwende FJ and Lewis RC. Determination of nicorandil in plasma using high-performance liquid chromatography with photo-conductivity and ultraviolet detection. Applications to pre-clinical pharamacokintics in regale dogs. Journal of Chromatography 1990; 525: 151.
11. Taira N. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates. Journal of Cardiovascular Pharmacology 1987; 10: S1.
12. Tanikawa M, Uzu M, Ohsawa Y and Fukushima M. Sensitive method for determination of nicorandil in human plasma by reversed-phase high performance liquid chromatography with ultraviolet detection. Journal of Chromatography 1993; 617: 163.